National Institutes of Biomedical Innovation, Health and Nutrition

  • Contact
  • Access
  • Sitemap
  • Japanese
Font Size
Medium
Large
Extra Large
  • About NIBIOHN
  • Research and Activities
  • Contact
  • Links

Home > Research and Activities > Laboratory of XNA Screening and Design

Laboratory of XNA Screening and Design

1. Members

Visiting Project Leader OBIKA Satoshi
Sub-Project Leader KASAHARA Yuuya
Research Assistant YAMAGUMA Harumi, SENGA Yoko, KAMEOKA Natsumi, ASO Kotomi
Visiting Researcher AKAGI Kenichi
Cooperative Researcher HOSHINO Hidekazu, Hao Ding, MATSUNAGA Taichi
Graduate Student ISHIDA Kenta

2. Background and objectives

In recent years, artificial nucleic acid (Xeno nucleic acid; XNA) developed by chemical technology has served as a medicine. To date, 15 types of nucleic acid drugs have been approved in Japan, the United States, and Europe. For example, antisense nucleic acids such as "Spinraza" and "Viltepso" and siRNAs such as "Onpattro" control the translation of target mRNA into protein. In addition, nucleic acid aptamer such as "Macugen" binds to the target protein and regulates its activity. As described above, there are various types of nucleic acid drug, and it is possible to target almost all the molecules existing in the living body such as DNA, RNA and protein. Nucleic acid drug leads to the development of a specific drug for intractable diseases that are difficult to treat with existing methods. In this project, synthesis of XNA to be introduced into nucleic acid drug such as antisense oligonucleotides and nucleic acid aptamers, and screening of sequence, and target specific nucleic acid is developed. In addition, we aim to create practical nucleic acid drugs by designing and optimizing the isolated hit molecules according to the application.

3. Overview of our research

Antisense oligonucleotides require characteristics such as binding affinity for target RNA, in vivo stability, intracellular migration and safety. Likewise, nucleic acid aptamers require characteristics such as in vivo stability, safety, binding affinity to target proteins, inhibitory activity, and retention in the body. In this project, we are developing XNA that modified the base part, sugar part, phosphoric acid part of nucleic acid to contain the above characteristics. We are also developing new screening methods that can efficiently screen active sequences from candidate sequence libraries. Especially in screening of nucleic acid aptamers, we are developing polymerase mutants that can extend XNAs. In this way, we conduct research aiming at the development of nucleic acid drug for various diseases including intractable rare diseases by consistently doing from synthesis of artificial nucleic acid to screening.

Laboratory of XNA Screening and Design

E-mail obika*nibiohn.go.jp (replace * by @)

Research and Activities

  • List

    NIBIO

    Coordination Office of Research Ethics
    Department of Research and Development
    Center for Rare Disease Research
    Reverse Translational Research Project
    Platform of Therapeutics for Rare Disease
    Laboratory of Rare Disease Information and Resource Library
    Laboratory of Animal Models for Human Diseases
    Center for Vaccine and Adjuvant Research
    Laboratory of Vaccine Materials
    Laboratory of Regulation of intractable Infectious Diseases
    Laboratory of Immunobiologics Evaluation
    Laboratory of Cell Vaccine
    Laboratory of Mockup Vaccine
    Center for Drug Design Research
    Laboratory of Proteomics for Drug Discovery
    Laboratory of Biopharmaceutical Research
    Laboratory of Antibody Design
    Laboratory of XNA Screening and Design
    Laboratory of Medicinal Plant Screening
    Laboratory of Pharmacokinetic Optimization
    Laboratory of Cell Network Regulation
    Laboratory of Bioimaging and Drug Discovery
    Laboratory of Advanced Biopharmaceuticals
    Laboratory of Clinical and Analytical Chemistry
    Artificial Intelligence Center for Health and Biomedical Research
    Laboratory of Bioinformatics
    Laboratory of In silico design
    AI nutrition project
    Laboratory of Toxicogenomics Informatics
    Laboratory of Proteome Research
    Laboratory of Stem Cell Regulation
    Laboratory of Hepatocyte Regulation
    Laboratory of Cell Cultures
    Section of Laboratory Equipment
    Section of Laboratory Animals
    Research Center for Medicinal Plant Resources
    Tsukuba Primate Research Center
    Laboratory of Infectious Diseases and Immunity
    Laboratory of Nuclear Transport Dynamics
    Laboratory of Gut Environmental System
    KAGAMI Project
    Laboratory of Immunosenescence

    NIHN

    Department of Nutritional Epidemiology and Shokuiku
    Section of the National Health and Nutrition Survey
    Section of Shokuiku
    Section of Dietary Guidelines
    Department of Physical Activity Research
    Section of Behavioral Physiology
    Section of Exercise Guideline
    Section of Healthy Longevity Researches
    Department of Clinical Nutrition
    Section of Nutritional Therapy
    Department of Nutrition and Metabolism
    Section of Chrononutrition
    Section of Energy Metabolism
    Department of Food Function and Labeling
    Section of Food Component Analysis
    Section of Food Safety and Function
    Section of Information Network of Health Food
    International Center for Nutrition and Information
    Section of International Nutrition Strategy
    Section of Population Health Metrics
    Section of Global Disaster Nutrition
    AI Nutrition Research team
    Section of Research Collaboration and Partnership

© National Institutes of Biomedical Innovation, Health and Nutrition. All Rights Reserved.

PAGE TOP